ProCE Banner Activity

Gaps in Patient‒HCP Communication Shown via Survey of Patients With Prostate Cancer

Clinical Thought

Released: June 07, 2023

Share

Faculty

Alicia Morgans

Alicia Morgans, MD, MPH

Associate ProfessorDana-Farber Cancer InstituteBoston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC., in partnership with ZERO Prostate Cancer

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC, Lilly, Merck Sharp & Dohme Corp., and Novartis.

AstraZeneca

Bayer HealthCare Pharmaceuticals Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Lilly

Merck Sharp & Dohme Corp.

Novartis

Partners

ZERO Prostate Cancer

ProCE Banner

Disclosure

Primary Author

Alicia Morgans, MD, MPH

Associate ProfessorDana-Farber Cancer InstituteBoston, Massachusetts

Alicia Morgans, MD, MPH: consultant/advisor/speaker: AAA, Astellas, AstraZeneca, Bayer, Exelixis, Janssen, Lantheus, Myovant, Myriad, Novartis, Pfizer, Sanofi, SeaGen, Telix.